We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Oversight Lands It on GAO’s At-Risk List
FDA’s Oversight Lands It on GAO’s At-Risk List
January 23, 2009
The FDA should protect the public more effectively by improving its oversight of devices, drugs and biologics, according to a government report that added the agency to a list of operations in need of transformation or at risk for mismanagement.